This page contains a Flash digital edition of a book.


Quest Diagnostics, specialist provider of diagnostic information services, is working with Montefiore Health System (MHS), in New York, to provide diagnostic laboratory services. This partnership will enhance the quality and efficiency of laboratory services at Montefiore.

Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics, said: "We are pleased to partner with Montefiore, a premiere academic health system recognised for personalised, accountable care.

"As part of our strategy to accelerate growth and drive operational excellence, Quest is collaborating with an increasing number of hospital partners, including leading academic institutions like Montefiore, which are looking to focus on their core business by taking advantage of our expertise, innovation and scale."

Quest will perform a portion of low complexity diagnostic tests at its Teterboro, NJ lab facility. The remainder of the laboratory testing will continue to be done at Montefiore Hospitals under the direction of the Montefiore and Einstein Department of Pathology.

Philip Ozuah, M.D., Ph.D. and Chief Operating Officer at Montefiore Health System, said: "Quest is a unique company committed to innovating new technologies and diagnostic capabilities.

"Most importantly, this new venture will allow Montefiore to maintain its laser focus on improving patient care and outcomes, while teaming up with a leader in the field who has access to the most sophisticated diagnostic equipment available."


Bard Pharmaceuticals Ltd, a Cambridge-based manufacturer, was the winner of a national Health and Safety Award at the EEF Future Manufacturing Awards held in London last week.

Bard Pharmaceuticals Ltd, part of the Napp Pharmaceutical Group, employs 406 staff and manufactures, packs and supplies pharmaceutical products to over 40 countries around the world. The company took gold in the Health and Safety Award, sponsored by Howden. The award recognises the manufacturer that has achieved the most impressive or innovative improvements in the health and safety culture of their workplace.

Bard Pharmaceuticals was selected by a panel of judges drawn from business leaders, industry experts and academics and was up against tough competition from a range of dynamic businesses, small and large, from across the UK.

The company impressed the judges by looking at health and safety issues in a truly innovative way that involved the entire workforce. Judges described the firm’s employee engagement on health and safety matters as ‘phenomenal’.

Runner-up for the award was Ideal Boilers, a Hull-based manufacturer of high quality Combi, system and new boilers.

Nick Bridge, Head of Health and Safety at Bard Pharmaceuticals, said: “Safety at work is a priority for us. This is why we have worked hard to adopt a more strategic approach, ensuring that health and safety is aligned with our company’s overall objectives and embedded in our culture.

“This award is an endorsement of the collaborative efforts required for successful implementation of safety initiatives and recognition of the hard work of every person in our organisation – we’re delighted to have won.”

Richard Storey, Executive Director at Howden, said: “Both Bard Pharmaceuticals and Ideal Boilers are great examples of companies that have moved health and safety out of ‘compliance’ and into the ‘innovation and opportunity’ box. Their commitment is paying off with high engagement levels and standards - undoubtedly this will lead to greater employee wellbeing and operational efficiency.” Tomorrow’s Laboratories | 15

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38